科学图书馆
-
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER TrialMurphy SA, Pedersen TR, Gaciong ZA et al. -
The Science Underlying COVID-19: Implications for the Cardiovascular SystemPP Liu, A Blet, D Smyth et al.
-
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-ITDL Bhatt, G Steg, and on behalf of the REDUCE-IT Investigators.
-
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical TrialJS Hochman, HR Reynolds, S Bangalore et al.
-
Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysisLin FY, Rosenbaum LR, Gebow D et al.
-
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trialsPM Ridker, DL Bhatt, AD Pradhan et al.
-
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)F Mach, C Baigent, ESC Scientific Document Group et al.
-
Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory DiseaseF Moroni, E Ammirati, AH Hainsworth et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
